Design Therapeutics (DSGN) Free Cash Flow: 2020-2021
Historic Free Cash Flow for Design Therapeutics (DSGN) over the last 2 years, with Dec 2021 value amounting to -$9.6 million.
- Design Therapeutics' Free Cash Flow fell 235.23% to -$9.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$30.9 million, marking a year-over-year decrease of 256.04%. This contributed to the annual value of -$43.4 million for FY2024, which is 26.13% up from last year.
- As of Q4 2021, Design Therapeutics' Free Cash Flow stood at -$9.6 million, which was down 4.92% from -$9.1 million recorded in Q3 2021.
- Over the past 5 years, Design Therapeutics' Free Cash Flow peaked at -$1.3 million during Q2 2020, and registered a low of -$9.6 million during Q4 2021.
- Its 2-year average for Free Cash Flow is -$4.9 million, with a median of -$3.3 million in 2020.
- Data for Design Therapeutics' Free Cash Flow shows a maximum YoY tumbled of 548.20% (in 2021) over the last 5 years.
- Over the past 2 years, Design Therapeutics' Free Cash Flow (Quarterly) stood at -$2.9 million in 2020, then crashed by 235.23% to -$9.6 million in 2021.
- Its last three reported values are -$9.6 million in Q4 2021, -$9.1 million for Q3 2021, and -$8.5 million during Q2 2021.